4-((3-Bromo-5-(trifluoromethyl)phenyl)sulfonyl)morpholine

Catalog No. :
ACPIUZ902
CAS No. :
951884-77-8
Molecular Formula :
C11H11BrF3NO3S
Molecular Weight :
374.18

IUPAC Name:4-((3-bromo-5-(trifluoromethyl)phenyl)sulfonyl)morpholine

4-((3-Bromo-5-(trifluoromethyl)phenyl)sulfonyl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$140.00Login to see priceInquiryInquiry
5g98%$447.00Login to see priceInquiryInquiry
10g98%$671.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((3-Bromo-5-(trifluoromethyl)phenyl)sulfonyl)morpholine
IUPAC Name4-((3-bromo-5-(trifluoromethyl)phenyl)sulfonyl)morpholine
MDL No.MFCD09801007
Molecular FormulaC11H11BrF3NO3S
Molecular Weight374.18
SMILESO=S(N1CCOCC1)(C2=CC(C(F)(F)F)=CC(Br)=C2)=O
InChI KeyJSASKMNWLZKWFC-UHFFFAOYSA-N
Synonym4-(3-Bromo-5-(trifluoromethyl)phenylsulfonyl)morpholine;4-(3-Bromo-5-trifluoromethylphenylsulfonyl)morpholine;Morpholine, 4-[[3-bromo-5-(trifluoromethyl)phenyl]sulfonyl]-
CAS No.951884-77-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPIUZ902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPIUZ902 route product structure diagram
    ACPIUZ902951884-77-8
Inquiry

2. ACPIUZ902 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPIUZ902 route product structure diagram
    ACPIUZ902951884-77-8
Inquiry

Comments (0)